labetalol has been researched along with Guillain-Barre Syndrome in 2 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
Guillain-Barre Syndrome: An acute inflammatory autoimmune neuritis caused by T cell- mediated cellular immune response directed towards peripheral myelin. Demyelination occurs in peripheral nerves and nerve roots. The process is often preceded by a viral or bacterial infection, surgery, immunization, lymphoma, or exposure to toxins. Common clinical manifestations include progressive weakness, loss of sensation, and loss of deep tendon reflexes. Weakness of respiratory muscles and autonomic dysfunction may occur. (From Adams et al., Principles of Neurology, 6th ed, pp1312-1314)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Guillain-Barré syndrome may result in hypertensive encephalopathy that can manifest as status epilepticus before the onset of motor symptoms." | 1.34 | Status epilepticus secondary to hypertensive encephalopathy as the presenting manifestation of Guillain-Barré syndrome. ( Abend, NS; Bonnemann, CG; Licht, DJ, 2007) |
| "This was manifested clinically by a seizure which began focally and became generalised." | 1.30 | Autonomic instability and hypertension resulting in subarachnoid haemorrhage in the Guillain-Barré syndrome. ( Gande, AR; Nolan, KM; Taylor, IR, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abend, NS | 1 |
| Bonnemann, CG | 1 |
| Licht, DJ | 1 |
| Gande, AR | 1 |
| Taylor, IR | 1 |
| Nolan, KM | 1 |
2 other studies available for labetalol and Guillain-Barre Syndrome
| Article | Year |
|---|---|
Status epilepticus secondary to hypertensive encephalopathy as the presenting manifestation of Guillain-Barré syndrome.
Topics: Adolescent; Amines; Anticonvulsants; Antihypertensive Agents; Cyclohexanecarboxylic Acids; Diagnosis | 2007 |
Autonomic instability and hypertension resulting in subarachnoid haemorrhage in the Guillain-Barré syndrome.
Topics: Antihypertensive Agents; Autonomic Nervous System Diseases; Diagnosis, Differential; Female; Guillai | 1999 |